BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15655717)

  • 1. GLP-1 and extra-islet effects.
    Ahrén B
    Horm Metab Res; 2004; 36(11-12):842-5. PubMed ID: 15655717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiological role of GLP-1 in human: incretin, ileal brake or more?
    Schirra J; Göke B
    Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
    Gromada J; Rorsman P
    Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
    List JF; Habener JF
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E875-81. PubMed ID: 15140754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of GLP-1 in the life and death of pancreatic beta cells.
    Perfetti R; Hui H
    Horm Metab Res; 2004; 36(11-12):804-10. PubMed ID: 15655712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1(GLP-1) in biology and pathology.
    Meier JJ; Nauck MA
    Diabetes Metab Res Rev; 2005; 21(2):91-117. PubMed ID: 15759282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
    Drucker DJ
    Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
    Egan JM; Bulotta A; Hui H; Perfetti R
    Diabetes Metab Res Rev; 2003; 19(2):115-23. PubMed ID: 12673779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic effects of GIP and GLP-1.
    Vella A; Rizza RA
    Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucagon-like peptide 1 on the hepatic glucose metabolism.
    D'Alessio D; Vahl T; Prigeon R
    Horm Metab Res; 2004; 36(11-12):837-41. PubMed ID: 15655716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.
    Larsen PJ; Holst JJ
    Regul Pept; 2005 Jun; 128(2):97-107. PubMed ID: 15780429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of beta-cell mass: recent progress and potential role of GLP-1.
    Stoffers DA
    Horm Metab Res; 2004; 36(11-12):811-21. PubMed ID: 15655713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for the treatment of type 2 diabetes mellitus based on incretin action.
    Gallwitz B
    Minerva Endocrinol; 2006 Jun; 31(2):133-47. PubMed ID: 16682937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the physiology of GIP and GLP-1.
    Holst JJ
    Horm Metab Res; 2004; 36(11-12):747-54. PubMed ID: 15655703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.